Schistosomiasis in Ogbese-Ekiti, re-infection after successful treatment with praziquantel

Urinary schistosomiasis in three different water-access in the Senegal River Basin: monitoring praziquantel efficacy and re-infection levels

Abstract Background Schistosomiasis is a neglected tropical disease most prevalent in sub

Safety of praziquantel in persons with and without schistosomiasis: systematic review and meta-analysis

ABSTRACT Millions of praziquantel doses have been delivered in schistosomiasis end

Reduction patterns of prevalence and intensity of Schistosoma haematobium infection after MDA with praziquantel between regions with and without previous intervention in Sudan

Abstract Background: Mass drug administration (MDA) with praziquantel has been the mainsta

Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment

Schistosomiasis is a parasitic disease infecting over 236 million people annually, with the majority

Utility of Repeated Praziquantel Dosing in the Treatment of Schistosomiasis in High-Risk Communities in Africa: A Systematic Review

Successful Treatment of Scabies with Oral Ivermectin in Nigeria

Currently, several topical scabicides are available but there is yet no oral or parenteral drug whic